14-day Premium Trial Subscription Try For FreeTry Free
9.10 Fr
+0.790 (+9.51%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 141.16 Fr 183.01 Fr Friday, 3rd May 2024 NWRN.SW stock ended at 9.10 Fr. This is 9.51% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 9.79% from a day low at 8.38 Fr to a day high of 9.20 Fr.
90 days 141.16 Fr 227.30 Fr
52 weeks 84.73 Fr 227.30 Fr

Historical Newron Pharmaceuticals S.p.A. prices

Date Open High Low Close Volume
May 03, 2024 8.40 Fr 9.20 Fr 8.38 Fr 9.10 Fr 206 489
May 02, 2024 8.20 Fr 8.74 Fr 7.90 Fr 8.31 Fr 164 467
Apr 30, 2024 9.00 Fr 9.29 Fr 7.75 Fr 8.21 Fr 817 574
Apr 29, 2024 7.59 Fr 7.90 Fr 7.06 Fr 7.64 Fr 80 143
Apr 26, 2024 6.71 Fr 7.29 Fr 6.71 Fr 7.28 Fr 59 319
Apr 25, 2024 6.93 Fr 6.93 Fr 6.52 Fr 6.69 Fr 63 463
Apr 24, 2024 7.18 Fr 7.18 Fr 6.85 Fr 7.00 Fr 43 337
Apr 23, 2024 7.29 Fr 7.29 Fr 6.85 Fr 7.00 Fr 32 127
Apr 22, 2024 6.90 Fr 7.27 Fr 6.90 Fr 7.18 Fr 62 322
Apr 19, 2024 6.70 Fr 7.29 Fr 6.51 Fr 6.95 Fr 209 831
Apr 18, 2024 7.46 Fr 7.46 Fr 6.10 Fr 6.68 Fr 162 247
Apr 17, 2024 7.33 Fr 7.33 Fr 7.06 Fr 7.25 Fr 39 647
Apr 16, 2024 7.60 Fr 7.76 Fr 7.22 Fr 7.22 Fr 57 671
Apr 15, 2024 7.40 Fr 7.70 Fr 7.32 Fr 7.42 Fr 56 713
Apr 12, 2024 7.40 Fr 7.89 Fr 7.40 Fr 7.69 Fr 48 062
Apr 11, 2024 7.54 Fr 7.62 Fr 7.31 Fr 7.35 Fr 69 148
Apr 10, 2024 7.68 Fr 7.88 Fr 7.52 Fr 7.58 Fr 64 304
Apr 09, 2024 8.30 Fr 8.30 Fr 7.57 Fr 7.66 Fr 56 250
Apr 08, 2024 8.30 Fr 8.30 Fr 7.65 Fr 7.69 Fr 78 814
Apr 05, 2024 8.29 Fr 8.40 Fr 8.00 Fr 8.10 Fr 39 642
Apr 04, 2024 8.57 Fr 8.57 Fr 8.10 Fr 8.15 Fr 80 094
Apr 03, 2024 8.03 Fr 8.84 Fr 8.01 Fr 8.49 Fr 97 124
Apr 02, 2024 8.00 Fr 8.28 Fr 7.74 Fr 8.09 Fr 98 678
Mar 28, 2024 8.00 Fr 8.10 Fr 7.56 Fr 7.76 Fr 88 879
Mar 27, 2024 7.50 Fr 8.00 Fr 7.36 Fr 7.84 Fr 85 665
Click to get the best stock tips daily for free!

About Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resi... NWRN.SW Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT